What is the recommended dosage of Trimethoprim (TMP)/Sulfamethoxazole (SMX) for the treatment of Methicillin-resistant Staphylococcus aureus (MRSA) skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trimethoprim-Sulfamethoxazole Dosage for MRSA Skin Infections

For MRSA skin infections, the recommended dosage of trimethoprim-sulfamethoxazole (TMP-SMX) is 1-2 double-strength tablets (160mg/800mg) twice daily for 5-10 days. 1

Oral Treatment Options for MRSA Skin Infections

  • TMP-SMX is a bactericidal agent with established efficacy against MRSA skin and soft tissue infections (SSTIs) 1
  • Standard adult dosing: 1-2 double-strength tablets (160mg/800mg) twice daily 1
  • Pediatric dosing: 8-12 mg/kg/day (based on the trimethoprim component) in either 4 divided doses IV or 2 divided doses orally 1
  • Duration of therapy: 5-10 days is recommended, based on clinical response 1

Evidence for TMP-SMX Efficacy in MRSA Skin Infections

  • TMP-SMX is recommended as first-line empiric therapy for community-acquired MRSA (CA-MRSA) skin infections 1
  • In a randomized controlled trial, TMP-SMX treatment resulted in higher cure rates for drained cutaneous abscesses compared to placebo in settings where MRSA was prevalent 2
  • For purulent cellulitis (cellulitis with purulent drainage or exudate), empirical therapy with TMP-SMX is recommended pending culture results 1

Dosage Considerations

  • Standard dose (160mg/800mg twice daily) versus high dose (320mg/1600mg twice daily) showed similar clinical resolution rates in patients with MRSA SSTIs 3
  • However, for pediatric patients with MRSA abscesses, a 10-day course of TMP-SMX was associated with lower failure and recurrence rates compared to a 3-day course 4
  • TMP-SMX may decrease formation of subsequent lesions after incision and drainage of uncomplicated abscesses 5

Alternative Oral Agents for MRSA Skin Infections

If TMP-SMX cannot be used, alternative oral options include:

  • Clindamycin: 300-450mg three times daily 1
  • Doxycycline or minocycline: 100mg twice daily (not recommended for children <8 years) 1
  • Linezolid: 600mg twice daily 1

When to Consider Intravenous Therapy

  • For complicated SSTIs (deeper infections, surgical/traumatic wound infections, major abscesses)
  • Options include vancomycin, linezolid, daptomycin, telavancin, or clindamycin 1
  • Duration of 7-14 days is recommended for complicated infections 1

Important Considerations and Caveats

  • Incision and drainage is the primary treatment for purulent skin abscesses; antibiotics are adjunctive therapy 1
  • Antibiotic therapy is recommended for abscesses with severe or extensive disease, rapid progression with cellulitis, systemic illness, immunosuppression, extremes of age, or difficult-to-drain locations 1
  • TMP-SMX has good activity against aerobes but poor activity against anaerobes 1
  • Gastrointestinal side effects (mostly mild) may occur with TMP-SMX 2
  • If coverage for both β-hemolytic streptococci and MRSA is desired, consider adding a β-lactam (e.g., amoxicillin) to TMP-SMX 1

Remember that clinical response should guide the duration of therapy, and cultures from abscesses are recommended to guide appropriate antibiotic selection 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.